Thymosin Alpha-1

Thymosin Alpha-1 – Benefits & Side Effects

Thymosin Alpha-1 – Protocol

Thymosin Alpha-1 – Lifestyle Considerations

Proper Peptide Storage

Why Proper Peptide Storage Matters

Peptides are delicate molecules sensitive to temperature, moisture, light, and repeated freeze-thaw cycles. Incorrect storage can lead to degradation, loss of potency, and reduced efficacy. Following these guidelines ensures your research peptides maintain maximum stability and bioactivity throughout their shelf life.

Lyophilized (Powder) Peptides

Optimal Storage:

• Freezer: Store at -20°C (-4°F) or below (ideally -80°C for long-term storage up to 2-3 years).
• Short-term: Refrigerate at 2-8°C (35.6-46.4°F) for weeks to months.
• Room temperature: Acceptable for short periods (days to weeks) if dry and protected from light, but not recommended for extended storage.
• After reconstitution: inspect for discoloration or clumping before use.

Key Practices:

• Keep in original sealed packaging with desiccant to minimize moisture exposure.
• Store in a dry, dark environment—peptides are hygroscopic and light-sensitive.
• Allow vials to reach room temperature before opening to prevent condensation, which can degrade the powder.

Reconstituted (Liquid) Peptides

Refrigeration is Essential:

• Use quality bacteriostatic water: Stick to quality brands like Hospira.
• Store at 2-8°C (35.6-46.4°F) immediately after reconstitution.
• Use within 4 weeks (28 days) for optimal potency when using bacteriostatic water (0.9% benzyl alcohol).
• Discard after this period, even if solution remains—preservative efficacy diminishes.

Important Warnings:

• Do NOT freeze reconstituted solutions—freezing denatures peptides.
• Avoid freeze-thaw cycles—they cause irreversible degradation. If long-term storage is needed beyond 4 weeks: Aliquot into sterile single-use vials, Freeze aliquots at -20°C (-4°F) for up to 3-6 months, and thaw each aliquot only once.

Handling Peptides Best Practices

1. Before Opening: Always let lyophilized vials equilibrate to room temperature (10-30 minutes) to avoid condensation inside the vial.
2. Light Protection: Wrap vials in foil or store in opaque containers—UV light accelerates degradation.
3. Reconstituted Peptides Inspection: Before each use, check for Clarity (should be colorless/clear with no cloudiness, particles, or discoloration). Discard if any issues observed.
4. Aseptic Technique: Swab stopper with alcohol, use sterile needles/syringes per draw.
5. Labeling: Mark reconstitution date on vials.

Common Peptide Storage Mistakes to Avoid

• Moisture Exposure: Never store open vials; always reseal tightly.
• Temperature Fluctuations: Avoid door storage in fridge/freezer.
• Heat/Light: Keep away from direct sunlight, heaters, or lab lights.
• Overuse of Multi-Dose Vials: Follow 28-day rule per USP/CDC guidelines.
• Freezing Liquids: Repeated cycles can reduce potency by 25%+ per cycle.

Special Peptide Considerations

• Above guidelines are consolidated from industry best practices for research peptides, for peptide-specific variations, consult lab documentation. Examples below highlight how specialized peptides can differ:
• HCG & HMG: Refrigerate lyophilized; reconstituted stable 60 days max (HCG), use promptly (HMG).
• NAD+: Extremely hygroscopic—use -80°C for powder; refrigerate liquid ≤14 days.
• PT-141: Room temp stable short-term; refrigerate reconstituted ≤1 week.

Subcutaneous Peptide Injection Protocol

Subcutaneous Peptide Injection Protocol Overview

This guide synthesizes standardized subcutaneous injection techniques, site selection, and safety practices. Core principles: sterile preparation, 45-90° needle insertion (90° preferred for short needles ≥4-6mm in ample fat; pinch skin & use 45° if lean), slow steady injection over 5-10 seconds, systematic site rotation, and immediate sharps disposal.

Preparation & Supplies

• Hand Hygiene: Wash thoroughly with soap and water.
• Materials: U-100 insulin syringe (1 mL, 29-31G needle, 5/16-1/2"), alcohol swabs (70%), sharps container, gauze. Use 30-50 unit syringes for volumes <10 units.
• Vial Prep: Wipe stopper, dry 10-30 seconds, draw dose, tap out air bubbles. Warm vials to room temperature to reduce stinging.
• Volume Limit: ≤1.5 mL per site; split larger doses (e.g., 75 IU into 3x25 IU). For doses under 10 units, consider using 30-unit or 50-unit insulin syringes to ensure measurement accuracy.

Site Selection & Rotation

Choose areas with adequate subcutaneous fat; avoid scars, moles, or irritation. Systematically rotate sites 1-1.5 inches apart; avoid same spot for 1-2 weeks. Log sites to prevent lipohypertrophy/lumping:

• Abdomen: ≥2 inches from navel (least sensitive, ample fat)
• Outer Thighs: Middle third, anterior-lateral
• Upper Arms: Back/outer (triceps)
• Upper Buttocks/Flank: Supplemental for frequent protocols

Peptide Injection Technique

Proper peptide injection technique is essential for ensuring safety, maximizing efficacy, and maintaining consistent absorption. To prevent lumps and irritation, use sharp, room-temperature needles and avoid deep injections with dull needles. Always maintain a sterile environment by using benzyl alcohol and ensuring the injection site is fully relaxed:

1. Clean site outward in circles; air-dry 30 seconds.
2. Pinch 1-2 inch skin fold to lift subcutaneous layer.
3. Insert needle at 45-90° angle (90° for ample fat, 45° for lean/thin needle).
4. No aspiration (pulling back plunger to check for blood)
5. Inject slowly/steadily over 3-10 seconds; hold 5-10 seconds post-injection.
6. Withdraw at same angle; gentle pressure if bleeding.
7. Dispose in sharps container immediately; never recap.
8. Discard any reconstituted solution if it becomes cloudy. Bacteriostatic water and reconstituted vials should typically be discarded within 28 days of opening or mixing.

Peptide Injection Timing Consideration

• Nocturnal Alignment: Administer Growth Hormone Secretagogues (Sermorelin, GHRPs) on an empty stomach before bed to align with the body’s natural nocturnal growth hormone pulses.
• Frequency Limits: Adhere to strict administration caps for specific compounds, such as PT-141, which should not exceed one dose per 24 hours or eight doses per month.
• Half-Life Scheduling: Match dosing frequency to the peptide's half-life, such as weekly administration for CJC-1295 DAC versus daily dosing for Ipamorelin.
• Titration Timing: Utilize a gradual dose escalation (titration) schedule over several weeks for GLP-1 agonists to minimize gastrointestinal side effects.
• Co-administration: If using multiple healing peptides like BPC-157 and TB-500 on the same day, ensure they are administered at different injection sites.
• Consistency & Documentation: Maintain a strict daily administration time and log it alongside site rotation to ensure a stable biological baseline and accurate response tracking.

Peptide Post-Injection Care & Risks

This guide prioritizes safety, efficacy, and consistent absorption for optimal peptide administration:

• Monitor for redness/swelling; rest site 1-7 days if severe.
• No massage (disrupts absorption).
• Document dose, site, time, reactions.
• Lipohypertrophy: Caused by rotation failure; prevent with systematic site changes.
• Pain/Lumps: From deep injection, cold solution, or dull needles.
• Infection: Maintain asepsis; monitor for fever/redness.

Thymosin Alpha-1 – Identification

Common Name(s): Thymosin Alpha-1, Thymosin α1, Thymosin-α1, Tα1, Thymalfasin (INN - International Nonproprietary Name), Zadaxin (brand name in some jurisdictions)

CAS Number: 62304-98-7 (free base)

CAS Number (Acetate Salt): Not separately registered; uses base CAS with notation of acetate salt form

Molecular Formula (Free Base): C₁₂₉H₂₁₅N₃₃O₅₅

Molecular Weight (Free Base): 3108.28–3108.32 Da or g/mol

PubChem CID: 16132303 (primary); 16130571 (thymalfasin synonym entry)

FDA UNII Code: W0B22ISQ1C (thymosin alpha-1 free base)

EINECS Number: 236-855-3

MDL Number: MFCD00076889

Origin & Type Classification:

• Source: Natural extraction from calf thymus tissue, followed by chemical synthesis; now commercially synthesized using solid-phase peptide synthesis

• Biosynthesis: Nonribosomal; isolated from thymic epithelial cell secretions or chemically synthesized

• Functional Class: Thymic peptide hormone, immunomodulator, immune system bioregulator, biological response modifier, antiviral agent

Amino Acid Sequence (28 amino acids - 28-mer peptide):

Complete Sequence (with N-terminal acetylation): Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH

Abbreviated Single-Letter Code: Ac-S-D-A-A-V-D-T-S-S-E-I-T-T-K-D-L-K-E-K-K-E-V-V-E-E-A-E-N-OH

Alternative Designation: H-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH (when showing hypothetical free amino terminus; naturally occurs acetylated)

Key Structural Features:

• N-Terminal Modification: N-acetylation at serine residue (acetyl group covalently attached to N-terminal amino group); this modification is essential for biological activity and protects the peptide from proteolytic degradation

• Structural Type: Linear polypeptide chain (not cyclic); 28 amino acid residues

• Amino Acid Composition: Contains no aromatic amino acids (no phenylalanine, tryptophan, or tyrosine residues), which contributes to its lack of UV absorption and thermal stability

• Elemental Composition: C 46.15%, H 6.34%, N 19.57%, O 27.94% (as percentage of molecular mass)

• Charge Distribution at Physiological pH (7.4): Multiple acidic residues (aspartic acid, glutamic acid) confer negative charge; one lysine residue and N-terminal amino group provide positive charges; net charge approximately −5 to −6 at pH 7.4

Physical Properties:

• Physical Form: White to off-white lyophilized (freeze-dried) powder; hygroscopic crystalline or amorphous solid

• Appearance: Fine white powder

• Solubility:

  • Deionized water: Soluble (up to 2 mg/mL at physiological pH)

  • PBS (pH 7.2): Soluble at physiological concentrations

  • DMSO: Soluble (≥1 mg/mL)

  • Ethanol: Slightly soluble

• pKa (Predicted): Approximately 3.5–4.0 (reflecting carboxyl groups of aspartate/glutamate residues)

• Thermal Stability: Remarkably stable at elevated temperatures; remains stable at 80–90°C for extended periods

• Stability: Protected from proteolytic degradation by N-acetylation; hygroscopic powder relatively stable at desiccated conditions

• Storage Requirements: Recommended storage −18°C or below for long-term stability (≥3 years); upon reconstitution, thymosin alpha-1 solutions remain stable 2–7 days at 4°C or indefinitely below −18°C

• Serum Half-Life (in vivo): Approximately 2 hours (or less) in humans after parenteral administration; short serum half-life is the primary limitation on clinical efficacy, prompting development of longer-acting Fc-fusion variants with half-lives of ~25 hours

Salt Forms & Formulations:

Thymosin Alpha-1 is commercially supplied in multiple salt and formulation options:

• Free Base (lyophilized powder; acetyl group present but no additional anion)

• Acetate Salt (monohydrate or polyhydrate; common commercial form enhancing stability)

• Trifluoroacetate (TFA) Salt (from HPLC purification; affects exact molecular weight)

• Fc-Fusion Protein (Tα1-Fc) (genetic engineering construct; combines Tα1 with Fc domain of human IgG4, extending half-life to ~25 hours)

• Recombinant/Biotechnologically Produced Tα1 (using prokaryotic Escherichia coli or eukaryotic expression systems)

Pharmaceutical formulations typically contain 1 mg/mL or 1.6 mg/mL solutions for subcutaneous or intramuscular injection.

Synonyms in Scientific Literature:

• Thymosin alpha-1

• Thymosin-α1

• Thymus Factor, Circulating (TFC)

• Prothymosin α cleavage product

• Immunomodulating peptide

• Thymic humoral factor (older terminology)

Database Links & Identifiers:

• PubChem CID: 16132303; 16130571 (thymalfasin entry)

• ChEMBL ID: CHEMBL1697578

• UniProt: P01102 (prothymosin-alpha; parent protein)

• InChIKey: HEEWEZGQMLZMFE-ANCKLJOMNA-N (or variant depending on acetylation state)

• Sigma-Aldrich Catalog: T3410 (≥90% HPLC purity)

• Cayman Chemical Catalog: 28748 (human, mouse, rat, bovine sequences - identical)

• FDA Drug Substance ID: Applicable for pharmaceutical formulations; bulk substance monographs exist

Thymosin Alpha-1 – Research

Thymosin Alpha-1 (often called Tα1 for short) is a tiny chain of amino acids (28 in a row) that scientists discovered inside your thymus gland—that same immune training camp in your chest. When researchers tested it on animals without a thymus, Tα1 brought their immune system back to life. It's been tested on millions of people worldwide since the 1980s and is one of the safest immune medicines we have. Unlike Thymalin (which is a mix of many peptides), Tα1 is pure and simple—just one specific molecule that does one job really well: it wakes up special immune cells called dendritic cells and tells them to activate your fighter T-cells. Think of dendritic cells as scouts—they find enemies (germs or cancer cells) and run back to tell the fighter cells "We found someone! Go get them!" Tα1 makes these scouts way more alert and talkative, so your fighter cells get activated faster and stronger.

Study: Immune Modulation with Thymosin Alpha 1 Treatment
Benefits: Wakes up dendritic cell scouts in your immune system, makes them send stronger messages to fighter T-cells, helps your body fight germs, cancer, and infections way better.
Link: https://pubmed.ncbi.nlm.nih.gov/27450734/
Summary: The key to Tα1's power is something called a Toll-like receptor—think of these as doorbells on immune cells. When Tα1 rings the doorbell, it activates two important types of immune cells: myeloid dendritic cells and plasmacytoid dendritic cells. Once these cells wake up, they flood the bloodstream with messenger proteins (cytokines) that tell fighter T-cells and natural killer (NK) cells to get to work. When you're sick with a serious infection, take chemotherapy for cancer, or get really old, your immune scouts get sleepy and lazy. They stop sounding the alarm, so your fighter cells don't know there's a problem. Tα1 is like smacking the snooze button and screaming "Wake up!" Within hours of getting Tα1, your dendritic cells are firing on all cylinders, and your fighter cells wake up and start hunting for trouble.

Study: Thymosin alpha 1: A comprehensive review of the literature
Benefits: Fixes weak immunity in sick and old people, helps COVID and cancer patients, safe to use for decades with almost no bad side effects.
Link: https://pubmed.ncbi.nlm.nih.gov/33362999/
Summary: Scientists looked at all the big studies on Tα1 going back many years. They found that Tα1 grows T-cells, calms over-reactions in COVID (when immune cells get confused and attack your own body), and boosts cancer treatments. Used for weak immune states from any reason, it repairs damage from too many fighter cells going crazy and prevents T-cell exhaustion (when fighter cells get so tired they just give up). During COVID-19, the sickest patients didn't die from the virus alone—they died because their immune system either shut down completely or went crazy and attacked their own lungs. Tα1 is perfect for this because it doesn't just activate the immune system blindly—it activates it smart and balanced.

Study: Thymosin alpha 1 treatment for patients with sepsis
Benefits: Cuts death risk in blood poisoning by waking up sleeping fighter cells, grows back low immune cell counts, stops extra dangerous infections from starting.
Link: https://pubmed.ncbi.nlm.nih.gov/30063866/
Summary: One of the scariest situations in hospitals is sepsis—when a bad infection spreads through your whole body and your organs start shutting down. It's like a house fire that spreads to the whole neighborhood. Doctors can give antibiotics to kill the germs, but if the patient's immune system is too weak to fight back, they die anyway. When doctors gave sepsis patients Tα1, something amazing happened. The T-cells in their blood woke up and started fighting, the number of immune markers on monocytes (another type of fighter cell) jumped way up, and patients had way fewer second infections and better survival rates. The peptide basically said to the sleepy immune system: "Your body is burning down—wake up and fight!" And it worked.

Thymosin Alpha-1 is like your immune system's greatest motivational coach—it wakes up sleeping fighters, organizes them smartly, and gets them fighting without letting them go crazy. For blood poisoning, serious infections, and immune weakness from age or sickness, Tα1 is a proven hero that's saved millions of lives over 40+ years.

Thymosin Alpha-1 – Research Links